Scharf, R E <br/><br/>
[Cancer, thromboembolia and antithrombotic                                         therapy: is there an anticoagulant of choice?].  [electronic resource] 

 -  Deutsche medizinische Wochenschrift (1946)  Nov 2011 
 - 2403 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1439-4413 
<br/><br/><label>Standard No.: </label>10.1055/s-0031-1292063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--adverse effects<br/>Heparin--administration & dosage<br/>Heparin, Low-Molecular-Weight--adverse effects<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Subcutaneous<br/>Long-Term Care<br/>Neoplasms--complications<br/>Patient Acceptance of Health Care<br/>Randomized Controlled Trials as Topic<br/>Secondary Prevention<br/>Survival Analysis<br/>Thrombin--antagonists & inhibitors<br/>Venous Thromboembolism--drug therapy<br/>Vitamin K--antagonists & inhibitors